Achieve Life Sciences Statistics
Total Valuation
ACHV has a market cap or net worth of $468.13 million. The enterprise value is $453.81 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHV has 102.66 million shares outstanding. The number of shares has increased by 39.99% in one year.
| Current Share Class | 102.66M |
| Shares Outstanding | 102.66M |
| Shares Change (YoY) | +39.99% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 2.55% |
| Owned by Institutions (%) | 34.32% |
| Float | 87.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 22.74 |
| P/TBV Ratio | 52.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.62, with a Debt / Equity ratio of 1.40.
| Current Ratio | 2.62 |
| Quick Ratio | 2.47 |
| Debt / Equity | 1.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -57.76 |
Financial Efficiency
Return on equity (ROE) is -496.15% and return on invested capital (ROIC) is -142.93%.
| Return on Equity (ROE) | -496.15% |
| Return on Assets (ROA) | -108.43% |
| Return on Invested Capital (ROIC) | -142.93% |
| Return on Capital Employed (ROCE) | -246.56% |
| Weighted Average Cost of Capital (WACC) | 16.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.86M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.00% in the last 52 weeks. The beta is 2.25, so ACHV's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | +50.00% |
| 50-Day Moving Average | 4.14 |
| 200-Day Moving Average | 4.11 |
| Relative Strength Index (RSI) | 48.11 |
| Average Volume (20 Days) | 1,260,927 |
Short Selling Information
The latest short interest is 6.89 million, so 6.71% of the outstanding shares have been sold short.
| Short Interest | 6.89M |
| Short Previous Month | 6.85M |
| Short % of Shares Out | 6.71% |
| Short % of Float | 7.90% |
| Short Ratio (days to cover) | 4.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.45M |
| Pretax Income | -51.99M |
| Net Income | -51.99M |
| EBITDA | -52.23M |
| EBIT | -52.45M |
| Earnings Per Share (EPS) | -$1.08 |
Full Income Statement Balance Sheet
The company has $29.27 million in cash and $14.95 million in debt, with a net cash position of $14.32 million or $0.14 per share.
| Cash & Cash Equivalents | 29.27M |
| Total Debt | 14.95M |
| Net Cash | 14.32M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 10.68M |
| Book Value Per Share | 0.20 |
| Working Capital | 19.23M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$45.31 million and capital expenditures -$3,000, giving a free cash flow of -$45.31 million.
| Operating Cash Flow | -45.31M |
| Capital Expenditures | -3,000 |
| Depreciation & Amortization | 223,000 |
| Net Borrowing | 5.00M |
| Free Cash Flow | -45.31M |
| FCF Per Share | -$0.44 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.99% |
| Shareholder Yield | -39.99% |
| Earnings Yield | -11.11% |
| FCF Yield | -9.68% |
Analyst Forecast
The average price target for ACHV is $13.11, which is 187.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.11 |
| Price Target Difference | 187.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2020. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jul 31, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |